Prostate Cancer
VA Launches Prostate Cancer Screening Study to Improve Early Detection, Personalize Recommendations
Premium
The study is evaluating the utility of a prostate cancer risk prediction model based on a polygenic score, family history, and a blended genome-exome sequencing approach.
Updated NCCN Guidelines Adjust Ratings for Prostate Cancer Genetic Tests
The newest version ups its endorsement of somatic genomic testing to "recommended" for advanced cancers and shifts its recommendations on early-stage risk assays.
NCCN Adds Prostate Cancer to Genetic Risk Assessment Guidelines
The NCCN also recently updated genetic risk guidelines for colorectal, endometrial, and gastric cancers.
As the company explores new testing areas and technologies, the prostate cancer prognostic has become an important backbone.
New Cancer Susceptibility Genes Identified in Germline Genetic Variation Study
Researchers tracked down six genes with ties to increased or decreased cancer risk in a study involving nearly 864,500 European ancestry individuals with or without cancer.